Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma

PURPOSE: To explore the utility of diffusion and perfusion changes in primary renal cell carcinoma (RCC) after stereotactic ablative body radiotherapy (SABR) as an early biomarker of treatment response, using diffusion weighted (DWI) and dynamic contrast enhanced (DCE) MRI. METHODS: Patients enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Hayley M., Parameswaran, Bimal K., Finnegan, Mary E., Roettger, Diana, Lau, Eddie, Kron, Tomas, Shaw, Mark, Chander, Sarat, Siva, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095575/
https://www.ncbi.nlm.nih.gov/pubmed/30114235
http://dx.doi.org/10.1371/journal.pone.0202387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095575/
https://www.ncbi.nlm.nih.gov/pubmed/30114235
http://dx.doi.org/10.1371/journal.pone.0202387

Ejemplares similares